Correlation of PD-L1 Expression Tested by 22C3 and SP263 in Non-Small Cell Lung Cancer and Its Prognostic Effect on EGFR Mutation–Positive Lung Adenocarcinoma

Correlation of PD-L1 Expression Tested by 22C3 and SP263 in Non-Small Cell Lung Cancer and Its Prognostic Effect on EGFR Mutation–Positive Lung Adenocarcinoma

Background Programmed death-ligand 1 (PD-L1) expression is tested by immunohistochemistry (IHC)—22C3, SP263, and SP142. The aim of this study is to evaluate the correlation among the three methods of PD-L1 IHC in non-small cell lung cancer (NSCLC) and clinical significance of PD-L1 expression i...

Full description

Bibliographic Details
Main Authors: Taehee Kim, M.D., Yoon Jin Cha, M.D., Ph.D., Yoon Soo Chang, M.D., Ph.D.
Format: Article
Language:English
Published: The Korean Academy of Tuberculosis and Respiratory Diseases 2020-01-01
Series:Tuberculosis and Respiratory Diseases
Subjects:
pd-l1
companion diagnotics
egfr
non-small cell lung cancer
Online Access:https://e-trd.org/search.php?where=aview&id=10.4046/trd.2019.0026&code=0003TRD&vmode=FULL

Internet

https://e-trd.org/search.php?where=aview&id=10.4046/trd.2019.0026&code=0003TRD&vmode=FULL

Similar Items